Cargando…

Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats

BACKGROUND: Fibrosis can be described as the excess deposition of extracellular matrix (ECM) components, such as collagens and proteoglycans. Fibrosis of the liver, which eventually leads to cirrhosis, is a major global health problem. Being able to measure fibrosis progression may enable timely pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Veidal, Sanne Skovgård, Vassiliadis, Efstathios, Bay-Jensen, Anne-Christine, Tougas, Gervais, Vainer, Ben, Karsdal, Morten Asser
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2860343/
https://www.ncbi.nlm.nih.gov/pubmed/20359335
http://dx.doi.org/10.1186/1755-1536-3-5
_version_ 1782180570744225792
author Veidal, Sanne Skovgård
Vassiliadis, Efstathios
Bay-Jensen, Anne-Christine
Tougas, Gervais
Vainer, Ben
Karsdal, Morten Asser
author_facet Veidal, Sanne Skovgård
Vassiliadis, Efstathios
Bay-Jensen, Anne-Christine
Tougas, Gervais
Vainer, Ben
Karsdal, Morten Asser
author_sort Veidal, Sanne Skovgård
collection PubMed
description BACKGROUND: Fibrosis can be described as the excess deposition of extracellular matrix (ECM) components, such as collagens and proteoglycans. Fibrosis of the liver, which eventually leads to cirrhosis, is a major global health problem. Being able to measure fibrosis progression may enable timely preventative intervention. The aim of the current study was to investigate the utility of serum procollagen type I N-terminal propeptide (PINP) as a marker of hepatic fibrosis, as distinct from bone formation, during three different periods of fibrosis development following hepatic injury induced by bile duct ligation (BDL) in rats. METHODS: BDL was performed on 30 female Sprague-Dawley rats aged 6 months, and sham operations on 30 controls. Animals were killed after 14, 28, or 35 days. The extent of liver fibrosis was evaluated by quantitative histology after Sirus Red staining. Levels of serum PINP and osteocalcin (a marker solely for osteoblastic bone formation) were determined using ELISA at baseline and post termination. RESULTS: Collagen formation increased by 30% compared to 3% in sham-operated animals (P < 0.0001). PINP levels increased significantly in all BDL groups compared with baseline (14 days: baseline 13.9 ng/ml, termination 17.7 ng/ml, P = 0.047; 28 days: baseline 17.9 ng/ml, termination 26.2 ng/ml, P = 0.005; 35 days: baseline 18.0 ng/ml, termination 27.4 ng/ml P = 0.015, an increase of 52%). PINP levels did not change from baseline in the sham-operated rats, indicating that the increased PINP levels were due to hepatic injury. The bone-specific marker, osteocalcin, did not increase in either BDL or sham-operated rats. PINP measured in serum correlated to the extent of liver fibrosis as evaluated by quantitative histology (R(2 )= 0.42, P < 0.001). CONCLUSION: PINP was associated with the development of liver fibrosis, but not bone formation, in mature rats subjected to BDL. Thus, PINP may be useful in studying the pathogenesis of liver fibrosis. However, caution should be applied when interpreting PINP levels in other disease states.
format Text
id pubmed-2860343
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28603432010-04-28 Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats Veidal, Sanne Skovgård Vassiliadis, Efstathios Bay-Jensen, Anne-Christine Tougas, Gervais Vainer, Ben Karsdal, Morten Asser Fibrogenesis Tissue Repair Research BACKGROUND: Fibrosis can be described as the excess deposition of extracellular matrix (ECM) components, such as collagens and proteoglycans. Fibrosis of the liver, which eventually leads to cirrhosis, is a major global health problem. Being able to measure fibrosis progression may enable timely preventative intervention. The aim of the current study was to investigate the utility of serum procollagen type I N-terminal propeptide (PINP) as a marker of hepatic fibrosis, as distinct from bone formation, during three different periods of fibrosis development following hepatic injury induced by bile duct ligation (BDL) in rats. METHODS: BDL was performed on 30 female Sprague-Dawley rats aged 6 months, and sham operations on 30 controls. Animals were killed after 14, 28, or 35 days. The extent of liver fibrosis was evaluated by quantitative histology after Sirus Red staining. Levels of serum PINP and osteocalcin (a marker solely for osteoblastic bone formation) were determined using ELISA at baseline and post termination. RESULTS: Collagen formation increased by 30% compared to 3% in sham-operated animals (P < 0.0001). PINP levels increased significantly in all BDL groups compared with baseline (14 days: baseline 13.9 ng/ml, termination 17.7 ng/ml, P = 0.047; 28 days: baseline 17.9 ng/ml, termination 26.2 ng/ml, P = 0.005; 35 days: baseline 18.0 ng/ml, termination 27.4 ng/ml P = 0.015, an increase of 52%). PINP levels did not change from baseline in the sham-operated rats, indicating that the increased PINP levels were due to hepatic injury. The bone-specific marker, osteocalcin, did not increase in either BDL or sham-operated rats. PINP measured in serum correlated to the extent of liver fibrosis as evaluated by quantitative histology (R(2 )= 0.42, P < 0.001). CONCLUSION: PINP was associated with the development of liver fibrosis, but not bone formation, in mature rats subjected to BDL. Thus, PINP may be useful in studying the pathogenesis of liver fibrosis. However, caution should be applied when interpreting PINP levels in other disease states. BioMed Central 2010-04-01 /pmc/articles/PMC2860343/ /pubmed/20359335 http://dx.doi.org/10.1186/1755-1536-3-5 Text en Copyright ©2010 Veidal et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Veidal, Sanne Skovgård
Vassiliadis, Efstathios
Bay-Jensen, Anne-Christine
Tougas, Gervais
Vainer, Ben
Karsdal, Morten Asser
Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats
title Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats
title_full Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats
title_fullStr Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats
title_full_unstemmed Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats
title_short Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats
title_sort procollagen type i n-terminal propeptide (pinp) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2860343/
https://www.ncbi.nlm.nih.gov/pubmed/20359335
http://dx.doi.org/10.1186/1755-1536-3-5
work_keys_str_mv AT veidalsanneskovgard procollagentypeinterminalpropeptidepinpisamarkerforfibrogenesisinbileductligationinducedfibrosisinrats
AT vassiliadisefstathios procollagentypeinterminalpropeptidepinpisamarkerforfibrogenesisinbileductligationinducedfibrosisinrats
AT bayjensenannechristine procollagentypeinterminalpropeptidepinpisamarkerforfibrogenesisinbileductligationinducedfibrosisinrats
AT tougasgervais procollagentypeinterminalpropeptidepinpisamarkerforfibrogenesisinbileductligationinducedfibrosisinrats
AT vainerben procollagentypeinterminalpropeptidepinpisamarkerforfibrogenesisinbileductligationinducedfibrosisinrats
AT karsdalmortenasser procollagentypeinterminalpropeptidepinpisamarkerforfibrogenesisinbileductligationinducedfibrosisinrats